United Kingdom· GB-APID-402711000001105
Farlutal 500 tablets
A medicinal product containing medroxyprogesterone, registered in United Kingdom by Pfizer Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Medroxyprogesterone
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Medroxyprogesterone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFarlutalParanova Oy
- CzechiaPROVERAPfizer, spol. s r.o., Praha
- SwitzerlandFarlutal
- SpainFARLUTAL 500 mg COMPRIMIDOSPfizer S.L.
- United StatesDepo-ProveraPharmacia & Upjohn Company LLC
- BelgiumDepo-Provera 1000, 1000 mgPfizer
- CanadaAA-MEDROXYAA PHARMA INC
- NetherlandsDepo-Provera 150, suspensie voor injectie 150 mg/mlPfizer B.V.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Depocon, Farlutal
- Belgium · Depo-Provera, Provera
- Bulgaria · Фарлутал
- Czechia · Depo-Provera, Provera
- Germany · Depo-Clinovir, Mpa
- Denmark · Depo-Provera, Provera
- Estonia · Farlutal
- Spain · Depo-Progevera, Progevera
- Finland · Farlutal, Provera
- France · Depo Prodasone, Depo Provera
- Croatia · Provera
- Hungary · Depo-Provera, Provera
- Ireland · Depo-Provera, Provera
- Iceland · Depo-Provera
- Italy · Depo-Provera, Farlutal
- Luxembourg · Depo-Provera, Provera
- Latvia · Depo-Provera
- Netherlands · Depo-Provera, Provera
- Norway · Depo-Provera, Provera
- Poland · Depo-Provera, Provera
- Portugal · Depo-Provera 150
- Sweden · Depo-Provera, Provera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/83a36a86-47b7-494a-97da-7dfa99b2264e GET /v1/drugs/83a36a86-47b7-494a-97da-7dfa99b2264e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "402711000001105",
"desc": "Farlutal 500 tablets (Pfizer Ltd)",
"form": "Oral tablet",
"vpid": "41879511000001106",
"source": "dmd",
"vtm_id": "776652008",
"strength": "500 mg",
"substance": "Medroxyprogesterone",
"ingredient": "Medroxyprogesterone acetate",
"supplier_code": "2082201000001106"
}See everything about medroxyprogesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.